Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Lawrence-based Ainstein taking flight with jetpack founder in Red Bull Air Race
When the founder of JetPack Aviation blasts to the sky later this month in Red Bull’s Air Race World Championship, it will be a testament to the innovation and quality at Ainstein, a Kansas radar tech firm, said Bryan C. Boots. “Although our products are widely deployed today in unmanned aviation (drone) applications, this will…
CreativeMornings KC relaunches with art culture, business community in focus
Artists are George Brooks’ people, the Crema co-founder and a co-host of the newly relaunched CreativeMornings KC guild said. “I love that CreativeMornings fosters the idea that we can all view our work, hobbies, and life through lenses of creativity,” Brooks said. “By bringing together a community of people who value creativity, it bridges the…
Advancing women as important now as ever, says STEMMy Awards leader
Women leave tech-intensive industries at a higher rate than their male counterparts because of a lack of encouragement and support, said Renee Keffer, citing a 2014 report by Catalyst. The fifth annual STEMMy Awards Gala aims to change that narrative in Kansas City, Keffer, co-chair of the event, said, but organizers need help: Nominations remain…
Kauffman Foundation’s Philip Gaskin sees entrepreneur ecosystems in the humble snowflake
Editor’s note: This content was sponsored by the Ewing Marion Kauffman Foundation but independently produced by Startland News. When it comes to developing a startup, there’s no better training ground than a political campaign, Philip Gaskin said. “You’re building movements of people to do extraordinary things,” said Gaskin, director of entrepreneurial communities and chief of…